Paula Marlton

Paula Marlton

UNVERIFIED PROFILE

Are you Paula Marlton?   Register this Author

Register author
Paula Marlton

Paula Marlton

Publications by authors named "Paula Marlton"

Are you Paula Marlton?   Register this Author

59Publications

1096Reads

14Profile Views

Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.

Intern Med J 2019 Sep;49(9):1070-1080

Division of Cancer Services, Clinical Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14268DOI Listing
September 2019

Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.

Intern Med J 2019 04;49(4):422-433

Clinical Haematology and School of Clinical Sciences, Monash Health, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14113DOI Listing
April 2019

FLT3-ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient management.

Asia Pac J Clin Oncol 2018 Dec 31;14(6):426-430. Epub 2018 Jan 31.

Cancer Care Services, Royal Brisbane and women's Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12827DOI Listing
December 2018

Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabine.

Eur J Haematol 2018 May 2. Epub 2018 May 2.

Department of Clinical Haematology and Bone Marrow Transplant, Royal Melbourne Hospital, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13089DOI Listing
May 2018

Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil.

Intern Med J 2017 Jul;47 Suppl 4:5-10

Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13493DOI Listing
July 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.6374
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.6374DOI Listing
May 2017

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.

Br J Haematol 2017 04 31;177(2):328-330. Epub 2016 Mar 31.

Department of Haematology, Alfred Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14063DOI Listing
April 2017

Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).

Eur J Haematol 2017 Feb 20;98(2):97-105. Epub 2016 Sep 20.

Thalassaemia Services Victoria, Monash Medical Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12793DOI Listing
February 2017

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

J Clin Oncol 2016 08 13;34(22):2575-82. Epub 2016 Jun 13.

Clémentine Sarkozy and Gilles Salles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hématologie, Pierre Bénite and Université Claude Bernard, Faculté de Médecine Lyon-Sud Charles Mérieux Pierre Bénite; Luc Xerri, Aix-Marseille University and Institut Paoli-Calmettes, Marseille; Pierre Feugier, Centre Hospitalier Universitaire de Nancy and INSERM 954 Université de Lorraine, Nancy; Pauline Brice, Hôpital Saint Louis APHP and Université Paris VII; Danielle Canioni, Assistance Publique Hôpitaux de Paris (APHP) Hôpital Universitaire Necker-Enfants Malades; Richard Delarue, APHP Hôpital Universitaire Necker-Enfants Malades and Descartes-Sorbonne Paris Cité University, Paris; Pierre Soubeyran, Institut Bergonié and Université Victor Segalen Bordeaux, Bordeaux; Christiane Mounier, Institut de Cancérologie Lucien Neuwirth, Saint Priest; Jehan Dupuis, Henri Mondor University Hospital, Créteil; Hervé Tilly, Université de Rouen, Rouen, France; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Nick Wickham, University of Adelaide, Adelaide; Marlton Paula, Princess Alexandra Hospital, University of Queensland School of Medicine, Brisbane; John Seymour, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia; Sirpa Leppa, Helsinki University Hospital Cancer Center and University of Helsinki, Helsinki, Finland; Maria Gomes Da Silva, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal; Fritz Offner, Gent University, Gent; Pierre Zachee, ZNA Stuivenberg, Antwerp, Belgium; and Dolores Caballero, Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7163DOI Listing
August 2016

The Perspectives of Haematological Cancer Patients on Tissue Banking.

Oncol Ther 2016 3;4(1):91-102. Epub 2016 May 3.

School of Medicine and Public Health, Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, NSW Australia ; Hunter Medical Research Institute, Newcastle, NSW Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40487-016-0019-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315074PMC
May 2016

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.

Blood 2016 Jan 20;127(2):208-15. Epub 2015 Oct 20.

Department I for Internal Medicine and Center of Integrated Oncology, University of Cologne, Cologne, Germany; Cluster of Excellence Cellular Stress Responses in Aging Associated Diseases, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-06-651125DOI Listing
January 2016

Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.

Nephrol Dial Transplant 2015 Oct 18;30(10):1774-9. Epub 2015 Jul 18.

Department of Haematology, Pathology Queensland and Cancer Services, Princess Alexandra Hospital, Brisbane, Australia School of Medicine, University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfv260DOI Listing
October 2015

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).

Br J Haematol 2014 Oct 11;167(2):243-51. Epub 2014 Jul 11.

Monash Medical Centre, Clayton, Vic., Australia; Australian Centre for Bloods Diseases, Monash University, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13029
Publisher Site
http://dx.doi.org/10.1111/bjh.13029DOI Listing
October 2014

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.

Asia Pac J Clin Oncol 2014 Sep 27;10(3):246-54. Epub 2014 Mar 27.

Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ajco.12188
Publisher Site
http://dx.doi.org/10.1111/ajco.12188DOI Listing
September 2014

The many facets of WT1 in acute myeloid leukemia: clarity remains elusive.

Authors:
Paula Marlton

Leuk Lymphoma 2014 Feb 24;55(2):235-7. Epub 2013 Jun 24.

Department of Haematology, Princess Alexandra Hospital , Brisbane , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.806804DOI Listing
February 2014

High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.

Genes Chromosomes Cancer 2013 May 23;52(5):467-79. Epub 2013 Jan 23.

Genomics Research Centre, Griffith Health Institute, Griffith University, Gold Coast, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22044DOI Listing
May 2013

WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation.

Leuk Res 2012 Apr 2;36(4):453-8. Epub 2011 Oct 2.

Department of Haematology, The Queen Elizabeth Hospital, Woodville South, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.09.005DOI Listing
April 2012

The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.

Blood Coagul Fibrinolysis 2012 Jan;23(1):45-50

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e32834d7ce3DOI Listing
January 2012

Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma.

Genes Chromosomes Cancer 2011 May 8;50(5):313-26. Epub 2011 Feb 8.

Genomics Research Centre, Griffith Health Institute, Griffith University, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20856DOI Listing
May 2011

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.

Ann Hematol 2011 Mar 6;90(3):359-60. Epub 2010 Jul 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-010-1023-0DOI Listing
March 2011

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.

BMC Cancer 2010 May 12;10:195. Epub 2010 May 12.

Genomics Research Centre, Griffith Institute for Health & Medical Research, Griffith University, Parklands Drive, Southport, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885361PMC
May 2010

High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma.

Leuk Res 2009 May 16;33(5):731-4. Epub 2008 Oct 16.

Genomics Research Centre, Griffith Institute for Health and Medical Research, Griffith University, Queensland 9726, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.09.007DOI Listing
May 2009

Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients.

Ann Hematol 2008 Sep 10;87(9):727-34. Epub 2008 Apr 10.

Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, Victoria 8006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-008-0488-6DOI Listing
September 2008

Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

Am J Hematol 2008 Apr;83(4):330-3

Department of Clinical Hematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21062DOI Listing
April 2008

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

Blood 2007 Aug 16;110(4):1326-9. Epub 2007 Apr 16.

Australian Centre for Vaccine Development, Tumor Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-066100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939905PMC
August 2007

Increased mortality with FLA compared with ADE chemotherapy in high-risk AML.

Blood 2006 Dec;108(12):3950-1; author reply 3951

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-06-032680DOI Listing
December 2006

Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.

Leuk Lymphoma 2006 Nov;47(11):2344-50

Division of Haematology & Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600881017DOI Listing
November 2006

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

Blood 2006 Oct 6;108(7):2280-9. Epub 2006 Jun 6.

Tumor Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-015164DOI Listing
October 2006

Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope.

J Immunol 2006 Oct;177(7):4897-906

Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Bancroft Centre, 300 Herston Road, Brisbane, Australia 4029.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.177.7.4897DOI Listing
October 2006

Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.

Leuk Lymphoma 2006 Sep;47(9):1813-7

Department of Haematology, School of Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Australia 4102.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600632832DOI Listing
September 2006

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Clin Cancer Res 2006 Jan;12(2):460-4

Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2008DOI Listing
January 2006

Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients.

Hematol J 2004 ;5(3):216-21

Department of Clinical Haematology and Bone Marrow Transplantation, The Alfred Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200342DOI Listing
September 2004

A rapid RT-PCR screening assay incorporating multiplexed validated control genes for CBF rearrangements at diagnosis in AML.

Pathology 2004 Aug;36(4):335-42

Queensland Health Pathology and Scientific Services, Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland 4101, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0031302042000224593DOI Listing
August 2004

A single-centre experience of post-renal transplant lymphoproliferative disorder.

Transpl Int 2003 Jul 7;16(7):529-36. Epub 2003 May 7.

Department of Renal Medicine, Level 2, Ambulatory Renal and Transplant Services Building, University of Queensland, Princess Alexandra Hospital, Ipswich Road, QLD 4102, Woolloongabba, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00147-003-0596-0DOI Listing
July 2003